-

Valor Compounding Pharmacy™ CEO Rick Niemi Named One of the 30 Best CEOs of the Year 2021

The Silicon Review® has honored CEO Rick Niemi with the distinction of 30 Best CEOs of the Year 2021

WALNUT, Calif.--(BUSINESS WIRE)--The Silicon Review®, a valuable resource bringing business leaders from several industries together, has named Rick Niemi, CEO and founder of Valor Compounding Pharmacy, as one of 30 Best CEOs of the Year 2021. Previous honorees ranked amongst Niemi included CEOs from the tech, cybersecurity, and medicine sectors. Niemi is recognized for his innovative approaches to custom medication and patient care which separates Valor from other compounding pharmacies in the industry. Specializing in compounded medication, Valor has built its brand around meeting the unique needs of each patient. Building on the layers of business and technology drives Valor towards their primary initiative, to make patients’ lives better.

“‘Life is better with Valor’ is our motto because we have found that many of our patients and prescribers appreciate how easy we make it to understand and obtain compounding options to treat medical illnesses or conditions,” says Rick Niemi, CEO & Founder of Valor Compounding Pharmacy. “Our mission is to increase awareness of and access to, compounded medication alternatives in the United States.”

The complete list of 30 Best CEOs of the Year 2021, including the companies that the honorees represent, can be found at https://thesiliconreview.com/magazine/profile/30-best-ceos-of-the-year-2021-listing. Niemi is featured in a Q&A interview where he explains Valor Compounding Pharmacy’s services in more detail.

Digitally published on December 10, 2020, The Silicon Review gives its readers a look at the successful minds that are running the companies that have been featured on their 30 Best CEOs of the Year 2021. As one of the recipients, Rick Niemi, joins the ranks as an innovative entrepreneur who looks to the motto “Life is better with Valor” as the inspiration for all the patients that Valor Compounding Pharmacy serves.

Niemi explains, “Our flat-rate pricing is one of the industry’s first in some categories, like hormone replacement, mental health solutions, and erectile dysfunction. Compounded medications can be costly at times, but Valor strives to advance its business with social impact of overall wellness in mind.”

About Valor Compounding Pharmacy: Valor Compounding Pharmacy™, Inc. is a multi-state licensed 503A facility housing both sterile and non-sterile laboratories, located in Berkeley, CA. PCAB accredited, Valor is a specialized pharmacy that makes custom medications to meet the unique needs of the individual patient. Our goal is to reinvent pharmacy from a reactive vendor to a proactive partner in patient health care. We do that by optimizing turnaround time, being data-driven, and reducing patient anxiety. Our focus is on non-sterile and sterile, hazardous and non-hazardous compounded medication, and we work with a network of providers, patients, health systems/institutions, and research scientists in multiple states in the United States.

More about The Silicon Review

The Silicon Review is the world’s most trusted online and print community for business & technology professionals. Our community members include thought-provoking CEOs, CIOs, CTOs, IT VPs and managers, along with jillions of diverse IT professionals.

Contacts

Rick Niemi
Valor Compounding Pharmacy
916.622.0267
RNiemi@vcprx.com

Valor Compounding Pharmacy


Release Summary
CEO Rick Niemi, of Valor Compounding Pharmacy, is honored as one of 30 Best CEOs of the Year 2021 by digital publication, The Silicon Review
Release Versions

Contacts

Rick Niemi
Valor Compounding Pharmacy
916.622.0267
RNiemi@vcprx.com

Social Media Profiles
More News From Valor Compounding Pharmacy

As Health Systems Rethink In-House Compounding, Valor Compounding Pharmacy Highlights How Outsourcing Low-Volume Prescriptions Saves Risk, Time, and Money

BERKELEY, Calif.--(BUSINESS WIRE)--As healthcare systems face increasing regulatory scrutiny and financial pressure, many are re-evaluating the value of maintaining in-house compounding operations for outpatient prescriptions. The reality: compounded medications serve a very small percentage of the patient population, yet require disproportionately high investment, compliance oversight, and staff time to sustain safety. Valor Compounding Pharmacy, a multi-state licensed 503a pharmacy headquarte...

Valor Compounding Pharmacy Announces Call for New Partnerships with Medical Practices and Hospital Systems

BERKELEY, Calif.--(BUSINESS WIRE)--Valor is a specialized pharmacy that prepares custom medications to meet the unique needs of the individual patient....

2022 Year-in-Review with Valor Compounding Pharmacy

BERKELEY, Calif.--(BUSINESS WIRE)--Valor Compounding Pharmacy closes the year achieving growth in multiple areas throughout its business while continuing to exceed customer satisfaction standards. Valor has expanded its state-of-the-art 503A facility that holds both sterile and non-sterile laboratories to a 6,421 square feet workspace to support its growing customer demand. After completing the expansion in the 3rd quarter of 2022, the compounding pharmacy relaunched its sterile operations, hav...
Back to Newsroom